- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease ; volume:14 ; number:1 ; day:2 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
Translational Psychiatry ; 14, Heft 1 (2.10.2024), 1-10, 12.2024
- Urheber
-
Gozes, Illana
Blatt, Jason
Lobyntseva, Alexandra
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41398-024-03118-0
- URN
-
urn:nbn:de:101:1-2412192123459.185898149666
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gozes, Illana
- Blatt, Jason
- Lobyntseva, Alexandra
- SpringerLink (Online service)
Ähnliche Objekte (12)
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease
Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease
Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease